Respiratory Syncytial Virus (RSV) Infection Overview

Save information for later
Sign Up

Learn About Respiratory Syncytial Virus (RSV) Infection

What is the definition of Respiratory Syncytial Virus (RSV) Infection?
Respiratory syncytial virus (RSV) is a common virus that causes infections of the respiratory tract and lungs. Respiratory syncytial virus mostly affects children but can also infect adults.
What are the symptoms of Respiratory Syncytial Virus (RSV) Infection?
Symptoms of respiratory syncytial virus can be similar to a mild cold in older, healthy children and adults. In babies under 12 months, premature infants, individuals with heart or lung disease, immunocompromised individuals, older adults, and individuals with other serious medical problems, respiratory syncytial virus can cause severe infection. Symptoms of respiratory syncytial virus infection usually appear within 4-to-6 days after infection. Symptoms of respiratory syncytial virus infection include decreased appetite, runny nose, congestion, cough, sneezing, fever, sore throat, headache, and wheezing. Symptoms of severe respiratory syncytial virus infection may also include fever; severe cough; wheezing; short, shallow, and rapid breathing or difficulty breathing; bluish skin; poor appetite; extreme fatigue; and irritability.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Respiratory Syncytial Virus (RSV) Infection?
Treatment for respiratory syncytial virus infection is focused on supportive and self-care, including over-the-counter pain medications, such as acetaminophen; saline nasal drops; cough medicine; and fluids. (Note that children should never be given aspirin. In addition, children under four years of age should not be given cough medicine unless prescribed by a physician.) Antibiotics may be prescribed if bacterial pneumonia develops. Patients with severe respiratory syncytial virus infection are treated in the hospital. In-hospital treatment for patients with severe respiratory syncytial virus infection may include intravenous fluids, antibiotics, humidified oxygen, intubation, and mechanical ventilation.
Who are the top Respiratory Syncytial Virus (RSV) Infection Local Doctors?
Ann R. Falsey
Elite in Respiratory Syncytial Virus (RSV) Infection
Dr. Ann R. Falsey
Infectious Disease
Elite in Respiratory Syncytial Virus (RSV) Infection
Dr. Ann R. Falsey
Infectious Disease

Infectious Disease Clinical

601 Elmwood Ave, 
Rochester, NY 
Languages Spoken:
English
See accepted insurances

Ann Falsey is an Infectious Disease provider in Rochester, New York. Dr. Falsey is rated as an Elite provider by MediFind in the treatment of Respiratory Syncytial Virus (RSV) Infection. Her top areas of expertise are Respiratory Syncytial Virus (RSV) Infection, Parainfluenza, Flu, and Severe Acute Respiratory Syndrome (SARS).

Octavio Ramilo
Elite in Respiratory Syncytial Virus (RSV) Infection
Dr. Octavio Ramilo
Pediatric Infectious Disease
Elite in Respiratory Syncytial Virus (RSV) Infection
Dr. Octavio Ramilo
Pediatric Infectious Disease
555 S 18th St, 
Columbus, OH 
614-722-6200
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Octavio Ramilo is a Pediatric Infectious Disease provider in Columbus, Ohio. Dr. Ramilo is rated as an Elite provider by MediFind in the treatment of Respiratory Syncytial Virus (RSV) Infection. His top areas of expertise are Respiratory Syncytial Virus (RSV) Infection, Parainfluenza, Infantile Neutropenia, and Kawasaki Disease. Dr. Ramilo is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Louis J. Bont
Elite in Respiratory Syncytial Virus (RSV) Infection
Louis J. Bont
Elite in Respiratory Syncytial Virus (RSV) Infection
Louis J. Bont
Utrecht, UT, NL 

Louis Bont practices in Utrecht, Netherlands. Mr. Bont is rated as an Elite expert by MediFind in the treatment of Respiratory Syncytial Virus (RSV) Infection. His top areas of expertise are Bronchitis, Respiratory Syncytial Virus (RSV) Infection, Parainfluenza, and Stridor.

View All Doctors
What are the latest Respiratory Syncytial Virus (RSV) Infection Clinical Trials?
An Open-Label Study to Assess the Safety and Efficacy of Remdesivir for Treatment of Symptomatic Laboratory-Confirmed Respiratory Syncytial Virus Infection of the Upper Respiratory Tract in Patients Receiving Cellular or Bispecific Antibody Therapies
An Open-Label Study to Assess the Safety and Efficacy of Remdesivir for Treatment of Symptomatic Laboratory-Confirmed Respiratory Syncytial Virus Infection of the Upper Respiratory Tract in Patients Receiving Cellular or Bispecific Antibody Therapies
Enrollment Status: Recruiting
Publish Date: September 29, 2025
Intervention Type: Other, Procedure, Drug
Study Phase: Phase 2

Summary: This phase II trial tests how well remdesivir works for treatment of respiratory syncytial virus (RSV) infection of the upper respiratory tract in patients receiving cellular or bispecific antibody therapy. Cellular or bispecific antibody therapies cause suppression of the immune system, making infections more frequent and reducing the body's ability to fight the infections. RSV infections are one...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Respiratory Syncytial Virus Infection in Exacerbations of Chronic Obstructive Pulmonary Diasease: the RECODE Study
Respiratory Syncytial Virus Infection in Exacerbations of Chronic Obstructive Pulmonary Diasease: the RECODE Study
Enrollment Status: Recruiting
Publish Date: February 26, 2025

Summary: The goal of this observational study is to determine the prevalence of respiratory syncytial virus (RSV) infection and evaluate its association with clinical outcomes in patients with chronic obstructive pulmonary disease (COPD) who experience exacerbations during the RSV season (October-April). The main question it aims to answer is: * What is the prevalence of RSV infection in patients with COPD...

View All Clinical Trials